Postmenopausal Osteoporosis
📧 Sign up to get email alerts when something new happens for Postmenopausal Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Double-blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis) [Phase 3]
This document reports results from a double-blind extension of the HORIZON Phase 3 trial evaluating zoledronic acid for fracture prevention …
-
CLINICAL_TRIALS trial_result · 2011-03-24Clinical Trial Update: Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women [Phase 2]
Phase 2 trial comparing delayed-release versus immediate-release risedronate in postmenopausal osteoporosis has completed and posted results…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation [Phase 4]
A Phase 4 trial comparing risedronate and raloxifene for discontinuation of hormone replacement therapy in postmenopausal osteoporosis has b…
-
CLINICAL_TRIALS trial_result · 2010-08-03Clinical Trial Update: Study of Transitioning From Alendronate to Denosumab [Phase 3]
Phase 3 trial evaluating transitioning from alendronate to denosumab for postmenopausal osteoporosis, with results posted in August 2010.
-
CLINICAL_TRIALS trial_result · 2010-07-30Clinical Trial Update: Motor Control Exercise in Osteoporotic Women [NA]
A clinical trial evaluating motor control exercise in osteoporotic, postmenopausal women has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-07-28Clinical Trial Update: Determine the Efficacy, Safety and Tolerability of Denosumab (AMG 162) in the Treatment of Postmenopausal Women With Low Bone Mineral Density [Phase 2]
Phase 2 trial results assessing the efficacy, safety and tolerability of denosumab (AMG 162) in postmenopausal women with low bone mineral d…
-
CLINICAL_TRIALS trial_result · 2010-07-12Clinical Trial Update: Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis [Phase 3]
Phase 3 trial comparing teriparatide to risedronate in women with spine fracture due to osteoporosis evaluated back pain outcomes. The study…
-
CLINICAL_TRIALS trial_result · 2010-06-14Clinical Trial Update: Bioequivalence Study of Alendronate Sodium Tablets 70 mg of Dr. Reddy's Under Fasting Conditions [Phase 1]
This entry reports the completion of a Phase 1 bioequivalence study of Dr. Reddy's Alendronate Sodium 70 mg tablets under fasting conditions…
-
CLINICAL_TRIALS trial_result · 2010-01-28Clinical Trial Update: Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis [Phase 3]
A Phase 3 trial comparing arzoxifene with raloxifene in postmenopausal osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density [Phase 2]
Phase 2 multicenter randomized, placebo-controlled pilot study using microCT to estimate the effects of denosumab (AMG 162) and alendronate …
-
CLINICAL_TRIALS trial_result · 2010-01-26Clinical Trial Update: Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis [Phase 3]
Phase 3 trial of denosumab (AMG 162) for prevention of postmenopausal osteoporosis completed; results were posted 2010-01-26.
-
CLINICAL_TRIALS trial_result · 2009-12-15Clinical Trial Update: Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women [Phase 3]
Phase 3 trial of risedronate for prevention of osteoporosis in osteopenic postmenopausal women has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-15Clinical Trial Update: Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women [Phase 3]
Phase 3 trial evaluating risedronate 75 mg given on two consecutive days each month for postmenopausal osteoporosis completed.
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: POWER Point of Care Effect on Satisfaction of Treatment [Phase 4]
Phase 4 trial completed, evaluating how POWER Point of Care affects treatment satisfaction in postmenopausal osteoporosis patients, sponsore…
-
CLINICAL_TRIALS trial_result · 2009-10-05Clinical Trial Update: A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation [Phase 1]
This is a Phase 1 study evaluating the effect of food on the intermittent formulation of ONO-5920/YM529 for osteoporosis. The trial status i…
-
CLINICAL_TRIALS trial_result · 2009-07-21Clinical Trial Update: A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva [Phase 4]
Phase 4 trial update reporting results for Bonviva (ibandronate) in women with postmenopausal osteoporosis who were previously treated with …
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Risedronate in the Prevention of Osteoporosis in Postmenopausal Women [Phase 4]
This Phase 4 trial update reports on risedronate for the prevention of osteoporosis in postmenopausal women; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2009-01-28Clinical Trial Update: Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D) [Phase 4]
Phase 4 trial evaluating the effect of monthly 150 mg oral ibandronate on bone structural properties in postmenopausal osteoporosis; study c…
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Combination Osteogenic Therapy in Established Osteoporosis [Phase 2]
Phase 2 trial update on a combination osteogenic therapy for osteoporosis, including postmenopausal osteoporosis.
-
CLINICAL_TRIALS trial_result · 2008-12-11Clinical Trial Update: Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects [Phase 1]
Phase 1 study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of escalating doses of PTH134 in healthy postmenopausal…
-
CLINICAL_TRIALS trial_result · 2008-05-01Clinical Trial Update: Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis [Phase 3]
This document reports the completion of a Phase 3 clinical trial evaluating teriparatide for osteoporosis in postmenopausal women.
-
CLINICAL_TRIALS trial_result · 2008-05-01Clinical Trial Update: Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis [Phase 3]
A Phase 3 trial comparing raloxifene hydrochloride to placebo for postmenopausal osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-11Clinical Trial Update: A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis [Phase 4]
Phase 4 study assessing satisfaction with Actonel in postmenopausal women with osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-11Clinical Trial Update: Risedronate Sodium in Post Menopausal Osteoporosis [Phase 4]
A Phase 4 clinical trial evaluating risedronate sodium for postmenopausal osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2008-01-24Clinical Trial Update: Natto Supplementation to Prevent Loss of Bone Mass in Women Immediately After Menopause [Phase 2]
A Phase 2 clinical trial evaluating natto supplementation to prevent loss of bone mass in women soon after menopause has completed.